These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Yellow fever: a decade of reemergence. Robertson SE; Hull BP; Tomori O; Bele O; LeDuc JW; Esteves K JAMA; 1996 Oct; 276(14):1157-62. PubMed ID: 8827969 [TBL] [Abstract][Full Text] [Related]
6. Resurgence of yellow fever. World Health Forum; 1993; 14(1):91-2. PubMed ID: 8439386 [No Abstract] [Full Text] [Related]
7. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. Staples JE; Bocchini JA; Rubin L; Fischer M; MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636 [TBL] [Abstract][Full Text] [Related]
8. Yellow fever, 1996-1997. Part II. Wkly Epidemiol Rec; 1998 Nov; 73(47):370-2. PubMed ID: 9844551 [No Abstract] [Full Text] [Related]
9. Benefit versus risk factors in immunization against yellow fever. Brès P Dev Biol Stand; 1979; 43():297-304. PubMed ID: 574841 [No Abstract] [Full Text] [Related]
16. Yellow fever in Africa and Central and South America, 2008–2009. Wkly Epidemiol Rec; 2011 Jan; 86(4):25-36. PubMed ID: 21268439 [No Abstract] [Full Text] [Related]
18. Yellow fever in Africa and South America, 2015. Wkly Epidemiol Rec; 2016 Aug; 91(32):381-8. PubMed ID: 27522678 [No Abstract] [Full Text] [Related]
19. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983]. Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474 [TBL] [Abstract][Full Text] [Related]
20. Review of the risks and benefits of yellow fever vaccination including some new analyses. Monath TP Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]